These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9925191)

  • 21. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
    Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological markers and psychosis.
    McGuffin P
    Psychol Med; 1984 May; 14(2):255-8. PubMed ID: 6588398
    [No Abstract]   [Full Text] [Related]  

  • 23. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients.
    Rothschild AJ; Schatzberg AF; Rosenbaum AH; Stahl JB; Cole JO
    Br J Psychiatry; 1982 Nov; 141():471-4. PubMed ID: 7150883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
    Ravindran AV; Bialik RJ; Lapierre YD
    J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine and sleep variables in major depressed inpatients: role of severity.
    Hubain P; Van Veeren C; Staner L; Mendlewicz J; Linkowski P
    Psychiatry Res; 1996 Jun; 63(1):83-92. PubMed ID: 8832777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtypes and laboratory measures of autonomous depression.
    Friedel RO
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):28-31. PubMed ID: 6807967
    [No Abstract]   [Full Text] [Related]  

  • 27. Melatonin in psychiatric disorders - subtyping affective disorder.
    Wahlund B
    Biol Signals Recept; 1999; 8(1-2):120-5. PubMed ID: 10085473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
    Maj M; Ariano MG; Arena F; Kemali D
    Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortisol suppression index in major depressive illness.
    Fraser A
    Aust N Z J Psychiatry; 1984 Sep; 18(3):277-9. PubMed ID: 6593060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term stability of polarity distinctions in the affective disorders.
    Coryell W; Endicott J; Maser JD; Keller MB; Leon AC; Akiskal HS
    Am J Psychiatry; 1995 Mar; 152(3):385-90. PubMed ID: 7864264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet monoamine oxidase in unipolar and bipolar depression.
    Trivedi JK; Lal N; Singh RP; Viswanathan PN
    Indian J Med Res; 1988 Aug; 88():165-8. PubMed ID: 3198176
    [No Abstract]   [Full Text] [Related]  

  • 32. Alpha 2-adrenoceptor levels on platelets of patients with major depressive disorders.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):321-31. PubMed ID: 3018817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet monoamine oxidase in affective disorders.
    Edwards DJ; Spiker DG; Kupfer DJ; Foster G; Neil JF; Abrams L
    Arch Gen Psychiatry; 1978 Dec; 35(12):1443-6. PubMed ID: 727880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis.
    Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessing the bipolar-unipolar dichotomy.
    Taylor MA; Abrams R
    J Affect Disord; 1980 Sep; 2(3):195-217. PubMed ID: 6176608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life events and biological vulnerability: a study of life events and platelet MAO activity in depressed patients.
    Perris H; von Knorring L; Oreland L; Perris C
    Psychiatry Res; 1984 Jun; 12(2):111-20. PubMed ID: 6591218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of growth hormone to desipramine in endogenous and non-endogenous depression.
    Dinan TG; Barry S
    Br J Psychiatry; 1990 May; 156():680-4. PubMed ID: 2095944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF; Shen YC; Shu LN; Lo HC
    Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizo-affective disorders: bipolar-unipolar subtyping. Natural history variables: a discriminant analysis approach.
    Van Eerdewegh MM; Van Eerdewegh P; Coryell W; Clayton PJ; Endicott J; Koepke J; Rochberg N
    J Affect Disord; 1987; 12(3):223-32. PubMed ID: 2956307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.